Literature DB >> 17245128

HIPK2: a versatile switchboard regulating the transcription machinery and cell death.

Marco A Calzado1, Florian Renner, Ana Roscic, M Lienhard Schmitz.   

Abstract

Homeodomain interacting protein kinase 2 (HIPK2) is an evolutionary conserved serine/threonine kinase that regulates gene expression by phosphorylation of transcription factors and accessory components of the transcription machinery. HIPK2 is activated in response to DNA-damaging agents or morphogenic signals and accordingly HIPK2-guided gene expression programs trigger differentiation and development or alternatively apoptosis. The kinase contributes to the regulation of remarkably diverse pathways such as p53 activation or Wnt signaling. Here we discuss recent findings from biochemical and functional experiments that allow a deeper understanding of the pleiotropic effects mediated by HIPK2.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245128     DOI: 10.4161/cc.6.2.3788

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  45 in total

1.  Tissue microarray cytometry reveals positive impact of homeodomain interacting protein kinase 2 in colon cancer survival irrespective of p53 function.

Authors:  Isabelle Soubeyran; Isabelle Mahouche; Aude Grigoletto; Thierry Leste-Lasserre; Guillaume Drutel; Christophe Rey; Stephane Pedeboscq; France Blanchard; Veronique Brouste; Jean-Christophe Sabourin; Yves Bécouarn; Josy Reiffers; François Ichas; Francesca De Giorgi
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  Wnt signaling through T-cell factor phosphorylation.

Authors:  Sergei Y Sokol
Journal:  Cell Res       Date:  2011-05-24       Impact factor: 25.617

3.  MUC1 oncoprotein suppresses activation of the ARF-MDM2-p53 pathway.

Authors:  Deepak Raina; Rehan Ahmad; Dongshu Chen; Shailendra Kumar; Surender Kharbanda; Donald Kufe
Journal:  Cancer Biol Ther       Date:  2008-12-09       Impact factor: 4.742

Review 4.  Posttranslational modifications regulate HIPK2, a driver of proliferative diseases.

Authors:  Vera V Saul; M Lienhard Schmitz
Journal:  J Mol Med (Berl)       Date:  2013-04-25       Impact factor: 4.599

5.  Homeodomain interacting protein kinase 2: a target for Alzheimer's beta amyloid leading to misfolded p53 and inappropriate cell survival.

Authors:  Cristina Lanni; Lavinia Nardinocchi; Rosa Puca; Serena Stanga; Daniela Uberti; Maurizio Memo; Stefano Govoni; Gabriella D'Orazi; Marco Racchi
Journal:  PLoS One       Date:  2010-04-14       Impact factor: 3.240

6.  Regulation of genotoxic stress response by homeodomain-interacting protein kinase 2 through phosphorylation of cyclic AMP response element-binding protein at serine 271.

Authors:  Kensuke Sakamoto; Bo-Wen Huang; Kenta Iwasaki; Kiros Hailemariam; Jun Ninomiya-Tsuji; Yoshiaki Tsuji
Journal:  Mol Biol Cell       Date:  2010-06-23       Impact factor: 4.138

7.  Different functions of HIPK2 and CtBP2 in traumatic brain injury.

Authors:  Feihui Zou; Jian Xu; Hongran Fu; Jianhua Cao; Hui Mao; Mingjie Gong; Gang Cui; Yang Zhang; Wei Shi; Jian Chen
Journal:  J Mol Neurosci       Date:  2012-10-18       Impact factor: 3.444

Review 8.  Regulation of Wnt/beta-catenin signaling by protein kinases.

Authors:  Esther M Verheyen; Cara J Gottardi
Journal:  Dev Dyn       Date:  2010-01       Impact factor: 3.780

9.  PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2: implications for leukemogenesis.

Authors:  Hee-Jun Wee; Dominic Chih-Cheng Voon; Suk-Chul Bae; Yoshiaki Ito
Journal:  Blood       Date:  2008-08-11       Impact factor: 22.113

10.  Targeting hypoxia in cancer cells by restoring homeodomain interacting protein-kinase 2 and p53 activity and suppressing HIF-1alpha.

Authors:  Lavinia Nardinocchi; Rosa Puca; Ada Sacchi; Gideon Rechavi; David Givol; Gabriella D'Orazi
Journal:  PLoS One       Date:  2009-08-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.